{"meshTagsMajor":["Gene Fusion"],"meshTags":["Antineoplastic Agents","Fibrosarcoma","Gene Expression Profiling","Gene Expression Regulation, Neoplastic","Gene Fusion","Humans","Infant","Lamin Type A","Lung Neoplasms","Molecular Targeted Therapy","Protein Kinase Inhibitors","Pyrazoles","Pyridines","Receptor, trkA","Reverse Transcriptase Polymerase Chain Reaction","Spinal Neoplasms","Treatment Outcome"],"meshMinor":["Antineoplastic Agents","Fibrosarcoma","Gene Expression Profiling","Gene Expression Regulation, Neoplastic","Humans","Infant","Lamin Type A","Lung Neoplasms","Molecular Targeted Therapy","Protein Kinase Inhibitors","Pyrazoles","Pyridines","Receptor, trkA","Reverse Transcriptase Polymerase Chain Reaction","Spinal Neoplasms","Treatment Outcome"],"publicationTypes":["Case Reports","Letter"],"title":"Evaluation of a Congenital Infantile Fibrosarcoma by Comprehensive Genomic Profiling Reveals an LMNA-NTRK1 Gene Fusion Responsive to Crizotinib.","pubmedId":"26563356"}